Jump to Content
Methodology and Scope Executive SummaryIndustry InsightsMarket Segmentation Region & Countries DataCompetitive Landscape List of TablesList of Figures
On This Report
Download Free Sample View Pricing
Home  ›  Industry Reports  › Markt für Gentherapie bei Hämophilie B

Marktgröße und Prognosen für die Gentherapie bei Hämophilie B 2026-2035, nach Segmenten (Patientenaltersgruppe, Schweregrad der Erkrankung), Wachstumschancen, Innovationslandschaft, regulatorische Veränderungen, strategische regionale Einblicke (USA, Japan, China, Südkorea, Großbritannien, Deutschland, Frankreich) und Wettbewerbsdynamik (uniQure, CSL Behring, Spark Therapeutics, BioMarin Pharmaceutical, Freeline Therapeutics)

Report ID: FBI 12277| Published Date: N/A| Format: PDF, Excel
Report Description Table of Contents (ToC) Request Free Sample Report →
Jump to content
Table of Contents (ToC)

Have a question about this report or need a custom scope?

Request Customization
LICENSE

Select License Type

Single User
US$ 4,250
Buy Now
Multi User
US$ 5,050
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →

Plant-based Eggs Market

Get a free sample of this report

Delivered to your inbox in PDF & Excel format

By submitting, you agree to our Privacy Policy. Your details stay confidential and are never shared.